EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus

Intrapartale Glukosemetriken und unerwünschte neonatale Outcomes bei Personen mit Gestationsdiabetes mellitus

Alexandra C Gallagher iD, Alyssa R Hersh iD, Lucy Ward, Amy M Valent iD

Pregnancy · 2026-05 · 2 (3)

DOI: 10.1002/pmf2.70308 ↗

Auf einen Blick

Bei 59 Gebärenden mit GDM war ein ungünstiges neonatales Outcome mit weniger Zeit im Zielbereich und mehr Zeit über dem Zielbereich während der Geburt verbunden.

Fragestellung

Unterscheiden sich CGM-Metriken unter der Geburt bei GDM zwischen Schwangerschaften mit und ohne zusammengesetztes unerwünschtes neonatales Outcome?

Methode

Sekundäranalyse einer Studie mit GDM-Teilnehmer:innen; Vergleich von CGM-Metriken unter der Geburt zwischen Personen mit und ohne zusammengesetztes neonatales Outcome.

Ergebnisse

59 von 111 Teilnehmer:innen gingen in die Analyse ein. Zielbereich 70–120 mg/dL: 62,7 % vs. 80,7 % (p = 0,012). Time-above-range ≥ 120 mg/dL: 26,7 % vs. 10,6 % (p = 0,007). Mittlere Glukose: 103,9 vs. 94,6 (p = 0,059).

Einschränkungen

52 von 111 Patient:innen wurden ausgeschlossen; 23 wegen fehlender intrapartaler Daten und 29 ohne Geburtsversuch vor Kaiserschnitt.

Schlussfolgerung der Autor:innen

Bei intrapartalen GDM-Teilnehmer:innen war ein zusammengesetztes unerwünschtes neonatales Outcome mit weniger TIR, mehr TAR und höherer mittlerer Glukose unter der Geburt verbunden.

Kernaussagen

  • TIR 70–120 mg/dL: 62,7 % vs. 80,7 %
  • TAR ≥ 120 mg/dL: 26,7 % vs. 10,6 %
  • Mittlere Glukose: 103,9 vs. 94,6; p = 0,059

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy, online erschienen am 15.05.2026. Verfasst von Alexandra C Gallagher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Obstetrics Stanford University Stanford California USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hyperglycemia is a recognized risk factor for adverse neonatal outcomes. However, the impact of achieving glucose goals during labor on the risk of such outcomes remains poorly understood for individuals with gestational diabetes mellitus (GDM). We sought to compare continuous glucose monitoring (CGM) metrics between laboring GDM pregnancies complicated by adverse neonatal outcomes to those without complications.

Methods

Secondary analysis of pregnant people with GDM randomized to using CGM versus capillary blood glucose (CBG) for management of GDM. Among all participants wearing a CGM during labor, we compared pregnancies that were complicated by a significant neonatal outcome as defined by a composite including one or more of the following: hypoglycemia, hyperbilirubinemia, respiratory distress syndrome, or neonatal intensive care unit admission to those without this composite adverse outcome. Continuous variables were compared with two‐sample t ‐tests, and categorical variables were tested with Fisher's Exact tests. We correlated antepartum to intrapartum glucose management by measuring mean glucose and glucose percent time‐in‐range (TIR; primary intrapartum range 70–120 mg/dL, with candidate ranges 70–110 and 70–140 mg/dL), stratified by composite adverse neonatal outcome.

Results

Of the 111 in the primary trial, 59 were included in this secondary analysis. A total of 52 of 111 patients in the primary trial were excluded, as 23 were missing intrapartum data and 29 had no trial of labor prior to cesarean delivery. The cohort with the composite adverse neonatal outcome spent significantly less intrapartum TIR between 70 and 120 mg/dL (62.7% vs. 80.7%, p = 0.012) and more time‐above‐range (TAR) ≥ 120 mg/dL (26.7% vs. 10.6%, p = 0.007) compared to those with no composite adverse neonatal outcome. The mean glucose for those with adverse neonatal outcomes was non‐significantly higher than those without (103.9 vs. 94.6, p = 0.059). There was a weak‐to‐moderate positive correlation between antenatal and intrapartum glucose management.

Conclusion

Intrapartum participants with GDM and a composite adverse neonatal outcome spent less TIR, more TAR, with a higher mean glucose in labor than those without a composite adverse outcome. A weak‐to‐moderate positive correlation between antenatal and intrapartum glucose management was observed.

Schlagwörter

Stichwörter der Autor:innen

continuous glucose monitoringgestational diabetesintrapartumneonatal hypoglycemia

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Obstetrics Stanford University Stanford California USA.
  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine Oregon Health & Science University Portland Oregon USA.

ORCID-Profile: Alexandra C Gallagher, Alyssa R Hersh, Amy M Valent

Zitieren

APA

Gallagher, A. C., Hersh, A. R., Ward, L., & Valent, A. M. (2026). Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus. Pregnancy, 2(3). https://doi.org/10.1002/pmf2.70308

Vancouver

Gallagher AC, Hersh AR, Ward L, Valent AM. Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus. Pregnancy. 2026;2(3). doi:10.1002/pmf2.70308

BibTeX
@article{Gallagher2026,
  author = {Gallagher, Alexandra C and Hersh, Alyssa R and Ward, Lucy and Valent, Amy M},
  title = {Intrapartum glucose metrics associated with adverse neonatal outcomes among people with gestational diabetes mellitus},
  journal = {Pregnancy},
  year = {2026},
  volume = {2},
  number = {3},
  doi = {10.1002/pmf2.70308}
}
Kostenlos starten →